Live Webinar Details
16:00-17:00 CET | 15:00-16:00 GMT | 10:00-11:00 EST
Thursday, February 2, 2017
Disruption of axonal transport is an early event in several neurodegenerative diseases. For this reason, it is a potential target for drug discovery.
This webinar will review:
Register today to hear more about this exciting topic, and have your questions answered by Dr Glennon during a live Q&A session!
Researchers at all levels interested in learning more about the role of axonal transport in neurodegenerative disease.
Meet the presenter
Elizabeth (Lizzie) Glennon studied her degree in biochemistry at the University of York (UK), followed by a PhD at the Univeristy of Leeds (UK), where she studied molecular mechanisms of neurodegeneration in Alzheimer's disease. Lizzie subsequently moved to King's College London, where she worked as a post doc investigating how a break down in axonal transport may contribute to development of Alzheimers disease.
Lizzie is now an Alzheimer's Research UK fellow at the Institute of Psychiatry, Psychology and Neuroscience at King's College London, where she is investigating how genes linked to Alzheimer's disease could affect the subcellular trafficking of the AD hallmark protein tau.
Email the Abcam Events Team for the answers.
Learn about the latest research when and where you want to with Abcam's on-demand webinar library!